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Abstract 
Background: Aboriginal Australians and Torres Strait Islanders (hereafter respectfully referred to as Indigenous Aus‑
tralians) experience disproportionately poor health and low life expectancy compared to non‑Indigenous Australians. 
Poor oral health is a critical, but understudied, contributor to this health gap. A considerable body of evidence links 
poor oral health to increased risks of other chronic non‑communicable conditions, such as diabetes, cardiovascular 
disease, chronic kidney disease, and poor emotional wellbeing. 
Main: The oral microbiota is indisputably associated with several oral diseases that disproportionately affect Indige‑
nous Australians. Furthermore, a growing literature suggests direct and indirect links between the oral microbiota and 
systemic chronic non‑communicable diseases that underpin much of the Indigenous health gap in Australia. Recent 
research indicates that oral microbial communities are shaped by a combination of cultural and lifestyle factors and 
are inherited from caregivers to children. Systematic differences in oral microbiota diversity and composition have 
been identified between Indigenous and non‑Indigenous individuals in Australia and elsewhere, suggesting that 
microbiota‑related diseases may be distinct in Indigenous Australians. 
Conclusion: Oral microbiota research involving Indigenous Australians is a promising new area that could benefit 
Indigenous communities in numerous ways. These potential benefits include: (1) ensuring equity and access for Indig‑
enous Australians in microbiota‑related therapies; (2) opportunities for knowledge‑sharing and collaborative research 
between scientists and Indigenous communities; and (3) using knowledge about the oral microbiota and chronic 
disease to help close the gaps in Indigenous oral and systemic health.
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Background
Aboriginal Australians and Torres Strait Islanders (here-
after respectfully referred to as Indigenous Australians) 
experience disproportionately poor health and lower life 
expectancy compared to non-Indigenous Australians. 
This has been described by the Australian Government 
as the Indigenous health gap [1]. Gaps in life expectancy 
and disease burden are largely driven by chronic non-
communicable diseases (NCDs). Although many factors 
contributing to this health gap are well-characterised, 
there is scant description of the oral microbiota in Indig-
enous Australians. This is despite growing evidence link-
ing oral microbiota to many oral and systemic chronic 
NCDs. To contribute to this knowledge gap, we review: 
(1) current evidence of the extent and causes of the Indig-
enous health gap in Australia; (2) the oral microbiota, 
its role in oral and systemic disease, and its influencing 
factors; and (3) the oral microbiota of Indigenous peo-
ples in Australia and elsewhere. We propose that the oral 
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microbiota is an important, yet under-studied, concept in 
Indigenous health research and outline both medical and 
non-medical potential benefits to Indigenous peoples 
that could result from microbiota research.
The Indigenous health gap in Australia
Indigenous Australians comprise two distinct First 
Nations groups in contemporary Australia. Aboriginal 
Australians are the first peoples of mainland Australia 
and Tasmania, while Torres Strait Islanders are the first 
peoples of islands located in the Torres Strait between 
Australia and Papua New Guinea [2]. The health dis-
parities experienced by Indigenous Australians in 
comparison to the non-Indigenous population are well-
documented. In 2018, the age-standardised death rate for 
Indigenous Australians was 1.7 times that of non-Indig-
enous people, while Indigenous Australians had a life 
expectancy approximately 8 years less than that of their 
non-Indigenous counterparts [3]. A large proportion of 
this death and disease burden can be attributed to NCDs 
such as cancers, diabetes, cardiovascular disease, ischae-
mic heart disease, chronic respiratory diseases, and poor 
mental health [4, 5]. Furthermore, several chronic NCDs 
exhibit both a higher incidence and higher death rate in 
Indigenous Australians compared to the non-Indigenous 
population. For example, Indigenous Australians have an 
incidence of diabetes 3.5 times higher, and a death rate 
from diabetes approximately 5 times higher, than non-
Indigenous Australians. The incidence and death rate for 
Indigenous Australians from chronic kidney disease are 
3.5 times and 2.6 times higher, respectively, than those 
of non-Indigenous Australians [4]. Addressing the bur-
den of chronic NCDs is therefore a priority in closing the 
Indigenous health gap in Australia.
Although less widely documented, poor oral health is 
another chronic NCD prevalent among Indigenous Aus-
tralians. Unfortunately, representative nationwide data 
on the oral health status of Indigenous Australians is lim-
ited. The 2017–18 National Survey of Adult Oral Health 
(NSAOH) reported that only 1.7% of participants who 
underwent dental examinations identified as Indigenous, 
compared to 2.4% of the Australian population in the 
2016 census [6]. Due to this small sample size and lack 
of representativeness, it is difficult to draw firm conclu-
sions about the oral health of Indigenous Australians 
from this survey, highlighting the need for more effective 
approaches to data collection on Indigenous Australian 
oral health.
Nevertheless, available evidence supports the exist-
ence of a substantial oral health gap within the overall 
Indigenous health gap, with Indigenous Australians expe-
riencing a high incidence and severity of oral diseases 
including dental caries (tooth decay), periodontal (gum) 
disease, and head and neck cancers [4, 7–12]. An earlier 
NSAOH  conducted in 2004–2006 reported an Indig-
enous participation rate similar to that identified in the 
2001 census [13]. The 2004–2006 NSAOH found that 
Indigenous Australians had “disproportionately elevated 
rates of tooth loss, untreated decay and tooth wear” and 
experienced worse oral health overall  than non-Indig-
enous counterparts [7]. Specifically, 57% of Indigenous 
participants in the 2004–2006 NSAOH experienced 
untreated dental caries, more than twice the proportion 
of non-Indigenous participants. The 2004–2006 NSAOH 
additionally found that Indigenous Australians experi-
enced a high prevalence of moderate or severe periodon-
tal disease compared to non-Indigenous counterparts [7]. 
A smaller convenience study of young adults in an Abo-
riginal birth cohort in the Northern Territory found a 
prevalence of untreated tooth decay 3.1 times higher, and 
of moderate or severe periodontal diseases 10.8 times 
higher, compared to age-matched NSAOH participants 
[8]. Research with otherwise healthy Aboriginal Austral-
ian adults in the Northern Territory found that 88% had 
moderate or severe periodontitis, equivalent to 3.5 times 
the estimated national average [9]. This suggests that the 
prevalence and severity of periodontal disease among 
Indigenous Australians may be much higher than what 
has been captured in nationwide surveys that do not spe-
cifically seek out Indigenous participants.
Indigenous Australians also experience a high burden 
of oral cavity and oropharyngeal cancers [10]. A recent 
review found Indigenous Australians are diagnosed with 
head and neck cancers at twice the rate of non-Indig-
enous Australians [4]. As of 2011, oral cavity and oro-
pharyngeal cancers were responsible for 7% of the total 
cancer burden for Indigenous Australians living in the 
state of Queensland, sharing third place with colorectal 
cancers [11]. Data from the state of South Australia indi-
cate that head and neck cancers represent approximately 
8% of cancer diagnoses in Aboriginal South Australians, 
compared to only approximately 2% of cancer diagnoses 
in non-Indigenous South Australians [12]. Furthermore, 
Aboriginal South Australians were more likely to be 
diagnosed with cancer at a later stage and had a signifi-
cantly lower 5-year survival rate from cancer compared 
to non-Indigenous counterparts [12]. Reflecting these 
state-level findings, cancer has recently overtaken car-
diovascular diseases as the leading cause of Indigenous 
deaths nationwide [3]. Therefore, despite gaps in the data, 
an overall picture emerges of considerably poorer oral 
health in Indigenous Australians in comparison to the 
overall Australian population.
Oral health is a particularly important, yet understud-
ied, contributor to the Indigenous health gap due to 
the numerous links between oral and systemic health. 
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Periodontal disease has been identified as a risk fac-
tor for many chronic NCDs, including diabetes [14–17], 
chronic kidney disease [18], cardiovascular disease [19, 
20], rheumatoid arthritis [21–24], and head and neck 
cancers [25, 26]. The mouth can also act as a reservoir 
for bacteria that can cause dangerous infections else-
where in the body, such as infective endocarditis [27, 
28]. Furthermore, poor oral health frequently has nega-
tive impacts on mental wellbeing and quality of life. For 
example, in a recent survey of urban Indigenous Aus-
tralian adults seeking primary healthcare, approximately 
40% of women and 25% of men reported recently experi-
encing oral pain or discomfort [29]. Similar proportions 
reported recently experiencing discomfort when eating 
because of oral health problems, while approximately 
24% of women and 14% of men reported recent sleep dis-
ruption due to pain from oral health problems [29]. Poor 
oral health has been associated with anxiety, depression, 
and suicidal thoughts in young Aboriginal Australian 
adults [30]. Therefore, improving oral health could lead 
to a lowered risk of chronic disease and infection as well 
as improved social and emotional wellbeing and overall 
quality of life for Indigenous Australians.
These observed disparities in both oral and overall 
health result from a complex mixture of factors. It is well 
established that people living in rural and remote areas 
of Australia often have poorer health outcomes than their 
urban counterparts. This is due, in part, to these areas 
having less health infrastructure and a smaller health 
workforce, particularly of specialist medical profession-
als [31]. A larger proportion of the Indigenous Australian 
population lives in outer regional or remote areas (39% of 
the Indigenous population vs 9.5% of the non-Indigenous 
population), which may contribute to health disparities 
between Indigenous and non-Indigenous Australians 
[32]. However, while many Indigenous Australians expe-
rience socioeconomic disadvantage or health challenges 
related to geographical remoteness, these factors do not 
fully explain the health gap. While Indigenous Austral-
ians are more likely than non-Indigenous Australians 
to live in rural and remote areas, the majority (60.1%) 
reside in metropolitan locations or inner regional areas 
[32]. A study of public dental patients in Australia found 
that Indigenous Australians experienced noteworthy dis-
parities in oral health even among an economically dis-
advantaged cohort [33]. Important physical risk factors 
for poor oral and overall health, such as overweight and 
obesity, tobacco smoking, and high levels of free sugar 
consumption, are comparatively prevalent among Indige-
nous Australians [4, 34]. Socioeconomic and cultural fac-
tors, including education and employment, the economic 
and social costs of obtaining healthcare, and racism and 
lack of cultural competence in the healthcare system, can 
prevent Indigenous Australians from seeking and receiv-
ing timely and appropriate care [7, 35–37]. Mistrust of 
the Australian government, unemployment, poor hous-
ing, high alcohol and sugar consumption, poor commu-
nication of health information, and lack of cultural and 
linguistic sensitivity in the Australian healthcare system 
have all been identified by Indigenous individuals and 
healthcare workers as factors contributing to the health 
burdens of Indigenous Australians [38–40].
Despite a range of initiatives attempting to address 
identified contributing factors, progress in closing the 
health gap to date has been limited [3, 36, 41, 42]. The 
Council of Australian Governments (COAG) first com-
mitted at the end of 2007 to an intention to close the gap 
in Indigenous life expectancy by 2030 [43]. Specific tar-
gets towards this goal, including closing the gap in life 
expectancy by 2031 and halving gaps in child mortality, 
literacy and numeracy skills, and employment by 2018, 
were set by COAG in 2008 [43]. In 2013, several new 
initiatives were announced by the Australian Govern-
ment, including the National Aboriginal and Torres Strait 
Islander Health Plan 2013–2023, a renewed national 
partnership agreement on closing the gap in Indigenous 
health outcomes, and an implementation plan for the 
National Aboriginal and Torres Strait Islander health 
plan [43]. However, an independent 10-year review of 
COAG’s Closing the Gap (CTG) strategy highlighted 
discontinuity, funding cuts, frequent changes in political 
leadership, and other factors that contributed to failures 
to meet CTG targets, concluding that “[b]y 2014–15, the 
CTG Strategy as a coherent, national response to Indig-
enous disadvantage was effectively over” [44]. The most 
recent Australian Government report on CTG noted 
that, while some improvements had been achieved in 
addressing socioeconomic determinants of health, such 
as educational attainment, the gaps in Indigenous adult 
and child and mortality rates had not narrowed and the 
target to close the gap in life expectancy was not on track 
[3]. In recognition of this lack of progress, Australian 
state and federal governments have recently announced 
a ‘reset’ of CTG targets with increased emphasis on 
Indigenous community control of efforts to close the 
gap, albeit without additional funding [45]. Inclusion of 
novel health-related factors, such as the human micro-
biota, in the Indigenous health management armamen-
tarium could help to further strengthen efforts to close 
the health gap.
The human oral microbiota in oral and systemic disease
The human oral microbiota refers to the collection of 
micro-organisms living in the human oral cavity. Within 
this collection, there are several distinct communities of 
microbes that establish themselves in different habitats. 
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The composition of these communities differs among 
different sites, such as the teeth, gingiva (gums), tongue, 
saliva, and the buccal mucosa (inside of the cheek) [46–
49]. Dental plaque, a microbial biofilm that grows on the 
surface of teeth, has a particularly distinct composition 
[47, 50]. Teeth are the only surface in the body that do 
not regularly shed cells, allowing a complex biofilm to 
flourish on the tooth surface [51]. Gram-positive primary 
colonisers such as Streptococcus and Actinomyces species 
first bind directly to the acquired pellicle, a thin layer of 
salivary glycoproteins on the tooth surface [52]. As the 
plaque community grows, it can incorporate ‘bridging’ 
organisms, such as Fusobacterium, that bind to both pri-
mary and late colonisers, and Gram-negative late colo-
nisers such as Porphyromonas species [52, 53]. Mature 
dental plaque is a highly structured community in which 
bacteria work together to optimise their access to appro-
priate resources [54]. Dental plaque, in the absence of 
regular oral hygiene, calcifies into a hardened calcium 
phosphate matrix known as dental calculus or tartar [55]. 
In this process, microbial DNA can be preserved in den-
tal calculus for thousands of years, allowing for the study 
of microbial communities through time [56]. Despite 
these useful qualities of dental plaque and calculus com-
munities, lower invasiveness and ease of collection has 
favoured the use of saliva as a proxy for studying the 
oral microbiota as a whole in modern-day populations. 
Although saliva may not represent a true microbial ‘com-
munity’, it can provide broad insight into the microbes 
present throughout the oral cavity [47, 50].
Oral microbial communities have been implicated in 
the most common oral diseases: dental caries, periodon-
tal disease, and oral cancers [57]. Dental caries affects 
approximately 90% of the global population and can be 
highly resistant to interventions [57–59]. This disease 
is primarily caused by oral bacteria fermenting sugars 
to acid, which in turn dissolves the enamel microstruc-
tures in the outer layer of the tooth to enable bacterial 
entry deeper into the tooth structure [60]. Streptococcus 
mutans and related oral bacteria (‘mutans streptococci’) 
have traditionally been considered the microorganisms 
responsible for caries [61–63]. However, this paradigm 
has been challenged by culture-independent research 
demonstrating that mutans streptococci can be detected 
in the oral microbiota of caries-free individuals and iden-
tifying alternative bacterial species associated with car-
ies [46, 64]. Hence, the oral health field has witnessed 
an increasing focus on the overall ecology of the oral 
microbiota in relation to caries, in particular the balance 
between acid-producing, acid-tolerant and alkali-pro-
ducing species and metabolic processes [65–68].
Periodontal disease refers to a group of conditions 
characterised by inflammation of the gingiva (gums), 
which can range from relatively mild and reversible gin-
givitis to severe periodontitis involving tissue destruc-
tion and loss of bone and teeth [69]. This inflammation is 
thought to constitute an immune reaction by the human 
host against resident oral bacteria. Although periodon-
titis is often characterised as a “polymicrobial infection” 
[70], a mixture of microbial, host, and environmental fac-
tors are likely required to produce the disease [71, 72]. 
Identification of specific pathogenic species in periodon-
tal disease [73, 74], such as the ‘red complex’ bacteria, 
has been complicated by culture-free microbiota studies, 
which have both expanded the list of putative periodontal 
pathogens [75–77] and identified changes in oral micro-
biota community structure, ecological diversity, and the 
relative abundance of specific microbial taxa in peri-
odontal disease compared to periodontal health [78–81]. 
These findings have formed the basis for new theories 
regarding periodontal disease, including the concepts 
of the ‘pathobiont’—a species that is normally harmless 
but has the potential to cause disease in a changed envi-
ronment—and the ‘keystone pathogen’—a species that 
can cause disease, even when present in low abundance, 
through its interactions with other microbes and with the 
host immune system [82, 83].
Recent research also supports a role for the oral 
microbiota in oral cancers. Several studies have found 
links between periodontal disease and increased risk of 
oral cancer [25, 26, 84]. These links may be mediated 
by the production of carcinogenic compounds by the 
oral microbiota, direct carcinogenic effects of specific 
microbes (particularly viruses), or the chronic inflamma-
tion resulting from periodontal disease [25, 85]. Although 
the role of the oral microbiota in oral cancer is a relatively 
new field of study, differences in the relative abundance 
of specific bacterial taxa and the presence of unique taxa 
in oral cancer compared to clinically healthy sites have 
been reported [86, 87], suggesting that the topic war-
rants further attention. For all three of these diseases, a 
deeper understanding of the role of the oral microbiota is 
needed to improve our ability to treat and prevent these 
conditions, especially in groups, such as Indigenous Aus-
tralians, who disproportionately experience poor oral 
health.
In addition to its roles in widespread oral diseases, the 
oral microbiota has direct and indirect impacts on many 
systemic diseases. On the one hand, there is consider-
able evidence to support a role for specific oral species 
in the initiation or progression of certain non-oral con-
ditions. A classic example is infective endocarditis, a 
life-threatening illness frequently triggered by oral Strep-
tococcus species [28, 88]. Although these species typically 
live harmlessly in the oral cavity, they can cause severe 
disease when they escape into the bloodstream (termed 
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bacteraemia) and colonise injured heart endothelial tis-
sue [88]. Another common oral species, Fusobacterium 
nucleatum, is frequently isolated from colorectal tumours 
and is thought to promote colorectal cancer through sev-
eral mechanisms, including promotion of a pro-inflam-
matory host response (reviewed in [89]) and tumour 
microenvironment [90], acceleration of cancer cell pro-
liferation through activation of Wnt/beta-catenin signal-
ling [91], interference with the host immune response 
[92, 93] and induction of chemotherapy resistance [94]. 
It has recently been shown that F. nucleatum strains from 
patient colorectal tumours are also found in saliva from 
the same individual, and most likely reach tumours by 
escape from the mouth into the bloodstream [95, 96]. A 
third example is the emerging evidence of a possible rela-
tionship between Porphyromonas gingivalis, an oral spe-
cies associated with periodontal disease, and Alzehimer’s 
disease (reviewed in [97]). P. gingivalis can escape from 
the mouth into the blood and colonise other tissues, 
while P. gingivalis products have been identified in brain 
autopsy specimens of humans and mice with Alzheimer’s 
disease. Therefore, while considerable research is needed 
to identify specific oral bacterial species and fully eluci-
date mechanisms linking them to various systemic con-
ditions, current evidence suggests that oral bacteria may 
play an important role in several diseases.
More generally, the association of periodontal disease 
with many chronic systemic conditions suggests that the 
oral microbiota as a whole may exert a substantial influ-
ence on overall health [98–100]. Although the mecha-
nisms that underlie these links are not fully understood, 
some hypotheses exist. Firstly, the observed relation-
ship between periodontal and systemic diseases could 
be based on shared risk factors, such as smoking [20, 
101]. Secondly, periodontal inflammation and bleed-
ing could facilitate bacteraemia caused by oral bacteria 
which, in turn, contributes to the initiation and mainte-
nance of systemic disease, as in the examples discussed 
in the previous paragraph [100, 102]. Thirdly, the long-
term inflammation stimulated by periodontal disease in 
the mouth could affect systemic immune function, con-
tributing to disease [16, 19, 100, 102–104]. For instance, 
recent evidence suggests that oral microbiota in peri-
odontal disease may inhibit normal macrophage polarisa-
tion and function [105]. Finally, a combination of these 
mechanisms could also act in tandem to promote disease. 
A summary of representative recent publications on pro-
posed links between the oral microbiota and non-oral or 
systemic NCDs is given in Table 1.
The oral microbiota of Indigenous peoples
The many host-related and environmental factors that 
shape the composition and activity of the oral microbiota 
represent an area of active research. Microbial com-
munity composition at different oral sites is influenced 
by local ecological factors such as nutrient and oxygen 
availability, pH, and salivary flow rate [106, 107]. The 
oral microbiota appears to be at least partly vertically 
transmitted from parent to child, although the rela-
tive importance of inherited host genetic factors versus 
parent-to-child transfer of microbes through physical 
contact and shared environment is debated [108–115]. 
A small number of studies have reported correlations 
between specific dietary nutrients and oral microbiota 
composition and diversity in modern humans, while 
major shifts in the oral microbiota composition of ancient 
Europeans have been attributed to dietary changes fol-
lowing the introduction of agriculture [116–118]. Cur-
rent evidence suggests that the oral microbiota is resilient 
to the effects of short-term antibiotic use, but clinical 
reports indicate that long-term, heavy antibiotic use can 
damage endogenous oral bacterial communities, in addi-
tion to having systemic impacts on the gut and inflam-
mation [60, 119]. Therefore, current evidence indicates 
that the oral microbiota is influenced by a combination of 
vertical transmission, host genetics, and lifestyle-related 
factors.
This evidence raises the pertinent question of whether 
the oral microbiota differs among human populations 
with different histories and cultures. Most oral micro-
biota research is conducted among people of predomi-
nantly European descent living industrialised lifestyles 
[120, 121]. However, reconstructions of ancient oral 
microbiota have identified shifts in microbiota composi-
tion that may be linked to major changes in lifestyle, such 
as meat consumption and transition to agriculture [116, 
122]. In three studies of the oral microbiota of modern-
day Indigenous populations living hunter-gatherer life-
styles in Venezuela, the Philippines, and Uganda, saliva 
samples from Indigenous individuals exhibited a micro-
bial composition distinct from that of industrialised or 
farming populations [123–125]. A fourth study found 
that Cheyenne and Arapaho Native Americans residing 
in towns in western Oklahoma had much higher variabil-
ity in oral microbiota composition than did non-Native 
individuals living nearby [120]. All four of these stud-
ies established differences in within-individual diversity 
(alpha diversity) and inter-individual variability (beta 
diversity) of the oral microbiota when comparing Indige-
nous to non-Indigenous individuals [120, 123–125]. Pre-
liminary work in Australia shows that the oral microbiota 
of Indigenous Australians living industrialised lifestyles 
differ significantly from those of non-Indigenous Austral-
ians [126]. Although current knowledge is not extensive 
and suffers from some limitations, it seems credible that 
Indigenous individuals may harbour oral microbiota that 
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differ in important ways from those of non-Indigenous 
individuals, even in a shared context of industrialisation.
A number of factors could plausibly influence the Indig-
enous Australian oral microbiota in unique ways. For 
example, smoking is more common among Indigenous 
Australians than in the overall Australian population, 
and has previously been shown to influence the com-
position of the oral microbiota [79, 127]. Diet may also 
influence the oral microbiota and is likely to vary among 
Indigenous Australians compared to non-Indigenous 
Table 1 Recent publications on direct and indirect links between oral microbiota and systemic NCDs
Representative articles and book chapters published since 2005 are listed, along with the non‑oral disease(s) and proposed mechanistic links with the oral microbiota 
discussed in each publication
Publication Non-oral disease(s) linked to oral microbiota Proposed mechanism(s)
Infective endocarditis
Kawamata et al. [27] [original research] Infective endocarditis Bacteraemia
Cahill and Prendergast [88] [review] Infective endocarditis Bacteraemia, colonisation of thrombus following 
endothelial injury
Colorectal cancer
Flemer et al. [141] [original research] Colorectal cancer Colonisation of colorectal tumour, shared risk factors, 
possibly Western diet
Komiya et al. [95] [original research] Colorectal cancer Colonisation of colorectal tumour from origins in the 
mouth
Abed et al. [96] [original research] Colorectal cancer Bacteraemia, colonisation of colorectal tumour via 
bloodstream
Central nervous system diseases
Ryder [97] [review] Alzheimer’s disease Bacteraemia, infiltration of central nervous system, 
gingipain activity
Ballini et al. [105] [original research] Central nervous system diseases Perturbed host tissue homeostasis and immune 
response, chronic host inflammatory response, 
carriage of pathogens between body sites by 
macrophages
Cardiovascular disease
Lockhart et al. [101] [review] Cardiovascular disease Shared risk factors, systemic host inflammatory 
response
Schenkein and Loos [104] [review] Cardiovascular disease Systemic host inflammatory response, cross‑reactive 
antibody production, promotion of dyslipidaemia, 
shared genetic susceptibility factors
Bansal et al. [102] [review] Cardiovascular disease Host inflammatory response, direct induction of 
inflammatory mediators by bacteria or bacterial 
products
Carrizales‑Sepùlveda et al. [19] [review] Cardiovascular disease Systemic host inflammatory response, oxidative stress, 
cross‑reactive autoantibody production, shared risk 
factors
Diabetes mellitus
Lalla and Papapanou [16] [review] Diabetes Systemic host inflammatory response, increased proin‑
flammatory cytokine production
Rheumatoid arthritis
Horz and Conrads [142] [review] Rheumatoid arthritis Host immune response
Bingham and Moni [22] [review] Rheumatoid arthritis Porphyromonas gingivalis enzyme activity, host inflam‑
matory response
Mutiple systemic diseases
Kim and Amar [103] [review] Cardiovascular disease, diabetes, adverse pregnancy 
outcomes, osteoporosis
Direct invasion of host tissues, systemic host inflam‑
matory response, changes in host proinflammatory 
cytokine and hormone levels, shared risk factors
Borgnakke [98] [review] Cardiovascular disease, diabetes, metabolic syn‑
drome, non‑alcoholic fatty liver disease, rheumatoid 
arthritis, chronic kidney disease
Bacteraemia, microbial dysbiosis, host inflammatory 
response, indirect stimulation of immune response 
by bacterial products
Guimarães et al. [99] [book chapter] Diabetes, cardiovascular disease Bacteraemia, host inflammatory response
Joshipura and Andriankaja 2016 [143] 
[book chapter]
Cardiometabolic conditions Common risk factors, host inflammatory response
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Australians. For instance, health survey data has reported 
that many Indigenous Australians obtain a comparatively 
large proportion (on average, 41%, compared to 35% for 
the overall Australian population) of their dietary energy 
from ‘discretionary’ foods such as confectionery, snack 
foods and alcohol [4, 128]. Reported consumption of free 
sugars is relatively high among Indigenous Australians 
[4], which may impact the oral microbiota by, for exam-
ple, favouring the growth of sugar-metabolising bacte-
ria. Traditional foods such as native game meats, certain 
insects, and native plants are rarely eaten by non-Indige-
nous Australians and may impart a unique effect on the 
oral microbiota, whether through the introduction of dif-
ferent environmental microbes or through other nutri-
ents or compounds that could affect resident microbial 
communities.
Finally, the evolutionary history of the microbiota in 
Australia may explain some differences between the 
oral microbiota of Indigenous and non-Indigenous Aus-
tralians. Archaeological and genetic evidence suggests 
that Aboriginal Australians had lived on Country (i.e. in 
specific homelands), in relative isolation from the rest 
of the world, for at least 50,000 years prior to European 
arrival [129, 130]. Under this scenario, we might expect 
that the microbiota of Indigenous Australians became 
uniquely adapted to the Australian environment and to 
aspects of human lifestyles, such as diet and medicines. 
Alternatively, even without specific adaptation, a process 
of random microbiota ‘drift’ as people settled in specific 
homelands may have led to variation in microbiota across 
the continent. As current evidence suggests that the oral 
microbiota is partly heritable, such historic variation in 
the microbiota could explain differences between the oral 
microbiota of Indigenous and non-Indigenous Austral-
ians, even when living relatively similar industrialised 
lifestyles today. Given the links between the oral micro-
biota and oral and systemic disease, such differences 
could have important implications for Indigenous health 
in terms of both disease risk and response to treatments. 
Indeed, Skelly et  al. [121] have previously argued that 
the traumatic experience of colonisation and its possi-
ble impacts on the human microbiome are likely to have 
health consequences for Indigenous people today.
Harnessing oral microbiota research to benefit Indigenous 
communities
There are numerous potential benefits from investigat-
ing the oral microbiota in Indigenous Australians. As 
reviewed above, a significant body of evidence points 
towards a central role for the oral microbiota in shap-
ing oral and overall health. The ability to understand 
and shape the microbiome to support human health 
holds considerable promise for addressing the burden of 
microbiome-mediated diseases, perhaps especially for 
groups whose access to medical care is compromised by 
structural issues such as geographic remoteness. Novel 
microbiome-based therapies, such as oral microbiota 
transplants [131, 132] and probiotic mouthwash or loz-
enges [133–138], are of increasing interest in the field of 
oral health promotion. However, factors including poor 
historical and continuing research practices when engag-
ing with Indigenous communities have led to a dearth of 
studies examining how the human microbiome medi-
ates disease in Indigenous populations [139]. Therefore, 
there is currently little understanding of how existing 
treatments may influence the microbiota of Indigenous 
populations and few attempts to verify that microbiome-
based therapies will be effective for these groups. Explicit 
inclusion of Indigenous Australians in oral microbiota 
research could help strengthen efforts to close the Indig-
enous health gap and to ensure that future health ben-
efits stemming from microbiota research in general are 
equitably shared. To realise this goal, it will be crucial 
to continue to strive for ethical and culturally appropri-
ate conduct of research, including commitment to the 
involvement and leadership of Indigenous researchers 
and communities in study design, data management and 
knowledge translation [106, 115].
Beyond these potential longer-term benefits, there are 
numerous opportunities for microbiota research to be a 
positive for Indigenous communities in the short term. 
Importantly, it may be some time before robust and suf-
ficiently powered microbiota research is carried out, 
analysed, and translated into new therapies or health-
care approaches with tangible benefits for Indigenous 
communities [121]. Valid concerns have previously been 
raised about the dangers of over-promising therapeutic 
benefits of microbiota research to research participants, 
especially for marginalised groups such as Indigenous 
peoples [140]. However, research could be designed in 
such a way as to provide other, non-medical benefits for 
Indigenous Australians in the shorter term. Oral microbi-
ota research could present opportunities for collaborative 
research partnerships between scientists and Indigenous 
communities, for two-way outreach and knowledge-
sharing, and for scientific training and capacity-building 
among Indigenous Australian communities through pro-
grams such as the Summer Internship for Indigenous 
Peoples in Genomics (SING) Australia.
Conclusion
Chronic systemic NCDs such as cardiovascular disease, 
diabetes, chronic kidney disease, and cancer dispropor-
tionately impact Indigenous Australians and have known 
associations with poor oral health. The human oral micro-
biota is linked to the pathogenesis of oral diseases that 
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severely affect Indigenous Australians. Current evidence 
suggests that oral microbiota composition and diversity 
differ between Indigenous and non-Indigenous people in 
Australia and elsewhere. Therefore, the oral microbiota and 
oral health are likely to be directly linked to oral and sys-
temic health outcomes in Indigenous peoples. Appropri-
ate inclusion of Indigenous Australians in oral microbiota 
research and further investigation of these links between 
the oral microbiota and oral and systemic disease is an 
important emerging strategy to help close the Indigenous 
health gap in Australia.
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